<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[clifford mintz Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/clifford+mintz.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to clifford mintz]]></description>
	<s:counts start="0" returned="1" found="1" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Merck - Schering Plough Under the Microscope: Why a Reverse Merger?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F125504-merck-schering-plough-under-the-microscope-why-a-reverse-merger%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Clifford Mintz submits: Some of you may have been wondering why the $41.1 billion Merck - Schering Plough merger announced Monday was designed as a reverse merger. For those of you who are not familiar with the reverse merger strategy, this is how it works. Generally speaking, a failing or...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 12 Mar 2009 08:22:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/clifford+mintz.html"><![CDATA[Clifford Mintz]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">MRK,SGP</category>
	</item>
</channel>
</rss>
